Topical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization

Author(s): Javed Ahmad*, Anuj Gautam, Shahadali Komath, Mehdiya Bano, Anuj Garg, Keerti Jain.

Journal Name: Recent Patents on Anti-Infective Drug Discovery

Volume 14 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Backgrounds: Acne vulgaris is a common chronic skin disease that affects around 9.4% (approx. 650 million people) of the global population. Growing research in the field of nanomedicine over the years has now been exploited in management of various human disorders. The nanomedicine concept has an immense opportunity for the effective management and control of acne disease by designing a novel, low-dose topical delivery system. Topical nanoemulsion-based gel preparations are said to have various benefits over the conventional formulations. The recent patents on topical anti-acne formulation (US 7241456B2; US 6897238B2; US 6284234B1) provided the concept to design thymol loaded nano-emulgel for topical application in acne.

Methods: The objective of the current investigation was to design a thymol loaded nanoemulgel preparation by exploiting low-energy emulsification method for topical application in acne. Furthermore, developed formulation was characterized for thermodynamic stability, mean droplet size, zeta potential, drug content and in-vitro drug diffusion study.

Results: The optimized thymol loaded nanoemulsion was found to be 13.60±0.117 nm with PdI 0.197±0.008. Nanoemulsions will provide an enormous surface area for better penetration of therapeutic agent into the pilosebaceous region, resulting better efficacy.

Conclusions: From the above studies, it concluded that aqueous-based gel vehicle of the developed formulation system exploited for topical delivery has moisturising properties which can improve local tolerability also.

Keywords: Acne vulgaris, nanoemulsion, thymol, pilosebaceous region, topical delivery, chronic skin disease.

[1]
Brown SK, Shalita AR. Acne vulgaris. Lancet 1998; 351: 1871-6.
[2]
Chandrashekhar BS, Anitha M, Ruparelia M, Vaidya P, Aamir R, Shah S, et al. Tretinoin nanogel 0.025% versus conventional gel 0.025% in patients with Acne vulgaris: A randomized, active controlled, multicentre, parallel group, phase IV clinical trial. J Clin Diagn Res 2015; 9(1): WC04-9.
[3]
Quan M, Strick RA. Management of Acne vulgaris. Am Fam Physician 1988; 38: 207-18.
[4]
Koo J. The psychosocial impact of acne: Patients’ perceptions. J Am Acad Dermatol 1995; 32: S26-30.
[5]
Rathi SK. Acne vulgaris treatment: The current scenario. Indian J Dermatol 2011; 56(1): 7-13.
[6]
Wolfstein R. Thyme oil and acne: An antibacterial powerhouse worth experimenting with. http://supernaturalacnetreatment.com/thyme-oil-kills-acne-bacteria-and-potentially-clears-acne/August 27 2015.
[7]
Marchese A, Orhan IE, Daglia M, Barbieri R, Di Lorenzo A, Nabavi SF, et al. Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem 2016; 210: 402-14.
[8]
Raman A, Weir U, Bloomfield SF. Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes. Lett Appl Microbiol 1995; 21(4): 242-5.
[9]
Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH. Tea tree oil reduces histamine-induced skin inflammation. Br J Dermatol 2002; 147(6): 1212-7.
[10]
Ajazuddin Alexander A. Khichariya A, Gupta S, Patel RJ, Giri TK, et al Recent expansions in an emergent novel drug delivery technology: Emulgel. J Control Release 2013; 171(2): 122-32.
[11]
Eid AM, El-Enshasy HA, Aziz R, Elmarzugi NA. Preparation, characterization and anti-inflammatory activity of Swietenia macrophylla nanoemulgel. J Nanomed Nanotechnol 2014; 5: 190.
[12]
Ahmad J, Kohli K, Mir SR, and Amin S. Self-emulsifying nano carriers for improved oral bioavailability of lipophilic drugs. Rev Adv Sci Eng 2012; 1(2): 134-47.
[13]
Taglietti M, Hawkins CN, Rao J. Novel topical drug delivery systems and their potential use in Acne vulgaris. Skin Therapy Lett 2008; 13: 6-8.
[14]
Yilmaz E, Borchert HH. Effect of lipid-containing, positively charged nanoemulsions on skin hydration, elasticity and erythema--an in vivo study. Int J Pharm 2006; 307(2): 232-8.
[15]
Gannu R, Palem CR, Yamsani VV, Yamsani SK, Yamsani MR. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: Formulation optimization, ex vivo and in vivo characterization. Int J Pharm 2010; 388: 231-41.
[16]
Vromen J. Formulations for topical delivery of bioactive substances and methods for their use. US7241456B2 (2007).
[17]
Anderson RR. Topical aminolevulinic acid-photodynamic therapy for the treatment of Acne vulgaris. US6897238B2 (2005).
[18]
Niemiec SM, Wang JC, Wisniewski SJ, Stenn KS, Lu GW. Topical delivery systems for active agents. US 6284234B1 (2001).
[19]
Chaudhry M, Naithani V. Topical herbal formulation for treatment of acne and skin disorders. US8268367B2 (2008).
[20]
Filippova IV, Filippov KL. Dermatological cream with natural ingredients base. US8613961B1 (2013).
[21]
Ahmad J, Kohli K, Mir SR, Amin S. Formulation of self-nanoemulsifying drug delivery system for telmisartan with improved dissolution and oral bioavailability. J Dispers Sci Technol 2011; 32: 958-68.
[22]
Ahmad J, Mir SR, Kohli K, Amin S. Quality by design approach for self nanoemulsifying system of paclitaxel. Sci Adv Mater 2014; 6: 1778-91.
[23]
Ahmad J, Mir SR, Kohli K, Amin S. Effect of oil and co-surfactant on the formation of Solutol HS 15 based colloidal drug carrier by Box–Behnken statistical design. Colloids Surf a Physicochem Eng Asp 2014; 453: 68-77.
[24]
Ahmad J, Mir SR, Kohli K, Chuttani K, Mishra AK, Panda AK, et al. Solid-nanoemulsion preconcentrate for oral delivery of paclitaxel: formulation design, biodistribution, and γ-scintigraphy imaging. BioMed Res Int 2014; 2014984756
[25]
Eshun K, He Q. Aloe vera: A valuable ingredient for the food, pharmaceutical and cosmetic industries--a review. Crit Rev Food Sci Nutr 2004; 44(2): 91-6.
[26]
De Paula IC, Ortega GG, Bassani VL, Petrovick PR. Development of ointment formulations prepared with Achyrocline satureioides spray-dried extracts. Drug Dev Ind Pharm 1998; 24(3): 235-41.
[27]
Barkat MA, Ahmad J. Harshita, Ali R, Rahman MA, Kaleem S, Singh SP, Ahmad FJ. Formulation design of micronized silver sulfadiazine containing aloe vera gel for wound healing. Curr Bioact Compd 2016; 12(2): 63-8.
[28]
Islam MT, Rodriguez-Hornedo N, Ciotti S, Ackermann C. Rheological characterization of topical carbomer gels neutralized to different pH. Pharm Res 2004; 21(7): 1192-9.
[29]
Amin S, Sarfenejad A, Ahmad J, Kohli K, Mir SR. Nanovesicular transfersomes for enhanced systemic delivery of telmisartan. Adv Sci Eng Med 2013; 5(4): 299-308.
[30]
Nava G, Pinon E, Mendoza L, Mendoza N, Quintanar D, Ganem A. Formulation and in vitro, ex vivo and in vivo evaluation of elastic liposomes for transdermal delivery of ketorolac tromethamine. Pharmaceutics 2011; 3(4): 954-70.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 1
Year: 2019
Page: [36 - 48]
Pages: 13
DOI: 10.2174/1574891X14666181129115213

Article Metrics

PDF: 14
HTML: 1